Pluristyx is a firm that supports drug development, regenerative medicine, and cell and gene therapies.The company is based in a Seattle, Washington.In July 2022, Pluristyx, panCELLa and Implant Therapeutics announced a definitive merger agreement.In January 2023, Pluristyx and panCELLa announced the granting of a patent used in their universal, off-the-shelf, induced pluripotent stem cells